Effect of Dipyridamole and Aspirin on Late Vein-Graft Patency after Coronary Bypass Operations

James H. Chesebro, Valentin Fuster, Lila R. Elveback, Ian P. Clements, Hugh C. Smith, David Holmes, William T. Bardsley, James R. Pluth, Robert B. Wallace, Francisco J. Puga, Thomas A. Orszulak, Jeffrey M. Piehler, Gordon K. Danielson, Hartzell V Schaff, Robert L. Frye

Research output: Contribution to journalArticle

361 Citations (Scopus)

Abstract

To study the prevention of occlusion of aortocoronary-artery bypass grafts, we conducted a prospective, randomized, double-blind trial comparing long-term administration of dipyridamole (begun two days before operation) plus aspirin (begun seven hours after operation) with placebo in 407 patients. Results at one month showed a reduction in the rate of graft occlusion in patients receiving dipyridamole and aspirin. At vein-graft angiography performed in 343 patients (84 per cent) 11 to 18 months (median, 12 months) after operation, 11 per cent of 478 vein-graft distal anastomoses were occluded in the treated group, and 25 per cent of 486 were occluded in the placebo group. The proportion of patients with one or more distal anastomoses occluded was 22 per cent of 171 patients in the treated group and 47 per cent of 172 in the placebo group. All grafts were patent within a month of operation in 94 patients in the placebo group and 116 patients in the treated group; late development of occlusions was reduced from 27 per cent in the placebo group to 16 per cent in the treated group. The results show that dipyridamole and aspirin continue to be effective in preventing vein-graft occlusion late after operation, and we believe that such treatment should be continued for at least one year. (N Engl J Med 1984; 310:209–14.).

Original languageEnglish (US)
Pages (from-to)209-214
Number of pages6
JournalNew England Journal of Medicine
Volume310
Issue number4
DOIs
StatePublished - Jan 26 1984

Fingerprint

Dipyridamole
Aspirin
Veins
Transplants
Placebos
Coronary Artery Bypass
Angiography
Arteries

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Chesebro, J. H., Fuster, V., Elveback, L. R., Clements, I. P., Smith, H. C., Holmes, D., ... Frye, R. L. (1984). Effect of Dipyridamole and Aspirin on Late Vein-Graft Patency after Coronary Bypass Operations. New England Journal of Medicine, 310(4), 209-214. https://doi.org/10.1056/NEJM198401263100401

Effect of Dipyridamole and Aspirin on Late Vein-Graft Patency after Coronary Bypass Operations. / Chesebro, James H.; Fuster, Valentin; Elveback, Lila R.; Clements, Ian P.; Smith, Hugh C.; Holmes, David; Bardsley, William T.; Pluth, James R.; Wallace, Robert B.; Puga, Francisco J.; Orszulak, Thomas A.; Piehler, Jeffrey M.; Danielson, Gordon K.; Schaff, Hartzell V; Frye, Robert L.

In: New England Journal of Medicine, Vol. 310, No. 4, 26.01.1984, p. 209-214.

Research output: Contribution to journalArticle

Chesebro, JH, Fuster, V, Elveback, LR, Clements, IP, Smith, HC, Holmes, D, Bardsley, WT, Pluth, JR, Wallace, RB, Puga, FJ, Orszulak, TA, Piehler, JM, Danielson, GK, Schaff, HV & Frye, RL 1984, 'Effect of Dipyridamole and Aspirin on Late Vein-Graft Patency after Coronary Bypass Operations', New England Journal of Medicine, vol. 310, no. 4, pp. 209-214. https://doi.org/10.1056/NEJM198401263100401
Chesebro, James H. ; Fuster, Valentin ; Elveback, Lila R. ; Clements, Ian P. ; Smith, Hugh C. ; Holmes, David ; Bardsley, William T. ; Pluth, James R. ; Wallace, Robert B. ; Puga, Francisco J. ; Orszulak, Thomas A. ; Piehler, Jeffrey M. ; Danielson, Gordon K. ; Schaff, Hartzell V ; Frye, Robert L. / Effect of Dipyridamole and Aspirin on Late Vein-Graft Patency after Coronary Bypass Operations. In: New England Journal of Medicine. 1984 ; Vol. 310, No. 4. pp. 209-214.
@article{8c99246f5fdc4fdfac5a94c98d2a70d2,
title = "Effect of Dipyridamole and Aspirin on Late Vein-Graft Patency after Coronary Bypass Operations",
abstract = "To study the prevention of occlusion of aortocoronary-artery bypass grafts, we conducted a prospective, randomized, double-blind trial comparing long-term administration of dipyridamole (begun two days before operation) plus aspirin (begun seven hours after operation) with placebo in 407 patients. Results at one month showed a reduction in the rate of graft occlusion in patients receiving dipyridamole and aspirin. At vein-graft angiography performed in 343 patients (84 per cent) 11 to 18 months (median, 12 months) after operation, 11 per cent of 478 vein-graft distal anastomoses were occluded in the treated group, and 25 per cent of 486 were occluded in the placebo group. The proportion of patients with one or more distal anastomoses occluded was 22 per cent of 171 patients in the treated group and 47 per cent of 172 in the placebo group. All grafts were patent within a month of operation in 94 patients in the placebo group and 116 patients in the treated group; late development of occlusions was reduced from 27 per cent in the placebo group to 16 per cent in the treated group. The results show that dipyridamole and aspirin continue to be effective in preventing vein-graft occlusion late after operation, and we believe that such treatment should be continued for at least one year. (N Engl J Med 1984; 310:209–14.).",
author = "Chesebro, {James H.} and Valentin Fuster and Elveback, {Lila R.} and Clements, {Ian P.} and Smith, {Hugh C.} and David Holmes and Bardsley, {William T.} and Pluth, {James R.} and Wallace, {Robert B.} and Puga, {Francisco J.} and Orszulak, {Thomas A.} and Piehler, {Jeffrey M.} and Danielson, {Gordon K.} and Schaff, {Hartzell V} and Frye, {Robert L.}",
year = "1984",
month = "1",
day = "26",
doi = "10.1056/NEJM198401263100401",
language = "English (US)",
volume = "310",
pages = "209--214",
journal = "New England Journal of Medicine",
issn = "1533-4406",
publisher = "Massachussetts Medical Society",
number = "4",

}

TY - JOUR

T1 - Effect of Dipyridamole and Aspirin on Late Vein-Graft Patency after Coronary Bypass Operations

AU - Chesebro, James H.

AU - Fuster, Valentin

AU - Elveback, Lila R.

AU - Clements, Ian P.

AU - Smith, Hugh C.

AU - Holmes, David

AU - Bardsley, William T.

AU - Pluth, James R.

AU - Wallace, Robert B.

AU - Puga, Francisco J.

AU - Orszulak, Thomas A.

AU - Piehler, Jeffrey M.

AU - Danielson, Gordon K.

AU - Schaff, Hartzell V

AU - Frye, Robert L.

PY - 1984/1/26

Y1 - 1984/1/26

N2 - To study the prevention of occlusion of aortocoronary-artery bypass grafts, we conducted a prospective, randomized, double-blind trial comparing long-term administration of dipyridamole (begun two days before operation) plus aspirin (begun seven hours after operation) with placebo in 407 patients. Results at one month showed a reduction in the rate of graft occlusion in patients receiving dipyridamole and aspirin. At vein-graft angiography performed in 343 patients (84 per cent) 11 to 18 months (median, 12 months) after operation, 11 per cent of 478 vein-graft distal anastomoses were occluded in the treated group, and 25 per cent of 486 were occluded in the placebo group. The proportion of patients with one or more distal anastomoses occluded was 22 per cent of 171 patients in the treated group and 47 per cent of 172 in the placebo group. All grafts were patent within a month of operation in 94 patients in the placebo group and 116 patients in the treated group; late development of occlusions was reduced from 27 per cent in the placebo group to 16 per cent in the treated group. The results show that dipyridamole and aspirin continue to be effective in preventing vein-graft occlusion late after operation, and we believe that such treatment should be continued for at least one year. (N Engl J Med 1984; 310:209–14.).

AB - To study the prevention of occlusion of aortocoronary-artery bypass grafts, we conducted a prospective, randomized, double-blind trial comparing long-term administration of dipyridamole (begun two days before operation) plus aspirin (begun seven hours after operation) with placebo in 407 patients. Results at one month showed a reduction in the rate of graft occlusion in patients receiving dipyridamole and aspirin. At vein-graft angiography performed in 343 patients (84 per cent) 11 to 18 months (median, 12 months) after operation, 11 per cent of 478 vein-graft distal anastomoses were occluded in the treated group, and 25 per cent of 486 were occluded in the placebo group. The proportion of patients with one or more distal anastomoses occluded was 22 per cent of 171 patients in the treated group and 47 per cent of 172 in the placebo group. All grafts were patent within a month of operation in 94 patients in the placebo group and 116 patients in the treated group; late development of occlusions was reduced from 27 per cent in the placebo group to 16 per cent in the treated group. The results show that dipyridamole and aspirin continue to be effective in preventing vein-graft occlusion late after operation, and we believe that such treatment should be continued for at least one year. (N Engl J Med 1984; 310:209–14.).

UR - http://www.scopus.com/inward/record.url?scp=0021335477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021335477&partnerID=8YFLogxK

U2 - 10.1056/NEJM198401263100401

DO - 10.1056/NEJM198401263100401

M3 - Article

C2 - 6361561

AN - SCOPUS:0021335477

VL - 310

SP - 209

EP - 214

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 1533-4406

IS - 4

ER -